Patents by Inventor Kevin Weber

Kevin Weber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thienopyranones as kinase inhibitors
    Patent number: 9981983
    Abstract: The invention relates to compounds of formula I (or pharmaceutically acceptable salts thereof) as defined herein, pharmaceutical compositions thereof, and their use in manufactures and methods for modulating biological processes including inhibition of kinase activity such as PI-3 kinase.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: May 29, 2018
    Assignee: SignalRx Pharmaceuticals, Inc.
    Inventors: Guillermo A. Morales, Kevin Weber, Jessica Newblom, Joseph R. Garlich
  • Thienopyranones as Kinase Inhibitors
    Publication number: 20170101419
    Abstract: The invention relates to compounds of formula I (or pharmaceutically acceptable salts thereof) as defined herein, pharmaceutical compositions thereof, and their use in manufactures and methods for modulating biological processes including inhibition of kinase activity such as PI-3 kinase.
    Type: Application
    Filed: December 14, 2016
    Publication date: April 13, 2017
    Applicant: SignalRx Pharmaceuticals, Inc.
    Inventors: Guillermo A. Morales, Kevin Weber, Jessica Newblom, Joseph R. Garlich
  • Thienopyranones as kinase inhibitors
    Patent number: 9550790
    Abstract: The invention relates to compounds of formula I (or pharmaceutically acceptable salts thereof) as defined herein, pharmaceutical compositions thereof, and their use in manufactures and methods for modulating biological processes including inhibition of kinase activity such as PI-3 kinase.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: January 24, 2017
    Assignee: SignalRx Pharmaceuticals, Inc.
    Inventors: Guillermo A. Morales, Kevin Weber, Jessica Newblom, Joseph R. Garlich
  • Thienopyranones as Kinase Inhibitors
    Publication number: 20140073584
    Abstract: The invention relates to compounds of formula I (or pharmaceutically acceptable salts thereof) as defined herein, pharmaceutical compositions thereof, and their use in manufactures and methods for modulating biological processes including inhibition of kinase activity such as PI-3 kinase.
    Type: Application
    Filed: September 30, 2013
    Publication date: March 13, 2014
    Applicant: SIGNALRX PHARMACEUTICALS, INC.
    Inventors: Guillermo A. Morales, Kevin Weber, Jessica Newblom, Joseph R. Garlich
  • SULFONYLETHYL PHOSPHORODIAMIDATES
    Publication number: 20080039429
    Abstract: Sulfonylethyl and thioethyl phosphorodiamidates, their preparation and intermediates in their preparation, formulations containing them, and their pharmaceutical use. The compounds are useful for treating cancer, alone and in combination with other anticancer therapies.
    Type: Application
    Filed: July 17, 2007
    Publication date: February 14, 2008
    Inventors: David Allen, Wenli Ma, Brian Peterson, Louise Robinson, Steven Schow, Songyuan Shi, Reyna Simon, Kevin Weber, Michael Wick
  • Sulfonylethyl phosphorodiamidates
    Publication number: 20050267075
    Abstract: Sulfonylethyl and thioethyl phosphorodiamidates, their preparation and intermediates in their preparation, formulations containing them, and their pharmaceutical use. The compounds are useful for treating cancer, alone and in combination with other anticancer therapies.
    Type: Application
    Filed: May 20, 2005
    Publication date: December 1, 2005
    Inventors: David Allen, Wenli Ma, Brian Peterson, Louise Robinson, Steven Schow, Songyuan Shi, Reyna Simon, Kevin Weber, Michael Wick
  • Guanidine compounds as anesthetics and for treatment of nervous system disorders
    Publication number: 20050228022
    Abstract: Novel guanidine compounds having the formula in which R1, R2 and R4 are as defined, are effective as sodium channel blockers in neuronal mammalian cells and as anesthetics and/or analgesics, particularly local spinal and/or epidural anesthetics, for alleviation of neuropathic pain, for providing a neuroprotective effect, and for producing anti-convulsant effects.
    Type: Application
    Filed: June 17, 2002
    Publication date: October 13, 2005
    Applicant: Taktix Corporation
    Inventors: Kenneth Drasner, Kevin Weber